**INTRODUCTION:** In response to a growing opioid crisis, there is an increased focus on reducing opioid consumption perioperatively. Pectoral nerve blocks (Pecs blocks) have previously been shown to successfully manage postoperative pain in mastectomy patients, decreasing perioperative opioid consumption and postoperative nausea. Over the past several years, we have begun incorporating Pecs blocks into our routine breast surgeries including reduction mammoplasty. The purpose of this study is to examine the impact of Pecs blocks on opioid consumption and antiemetic requirement in reduction mammoplasty patients.

**METHODS:** We performed a retrospective review of all patients who underwent reduction mammoplasty between 2014--2016. All Pecs blocks were performed with ropivacaine under ultrasound guidance by the anesthesia team after induction of general anesthesia, but prior to the start of the operation. Demographics, operative details, opioid and antiemetic use, and complications were recorded. Opioid consumption was converted to a standardized oral morphine equivalence (OME) value for comparison. Outcomes of patients who received Pecs blocks were compared against those who did not.

**RESULTS:** Seventy patients underwent reduction mammoplasty by four different attending plastic surgeons at our institution. Twenty-nine patients received Pecs blocks in addition to general anesthesia, while 41 patients received only general anesthesia without a Pecs block. These groups were similar with respect to age, BMI, average breast tissue resection, and follow up time. Performing the Pecs block added approximately 10 minutes of anesthesia time to the patients' case. Notably, intraoperative morphine consumption was significantly lower (85.03 vs 105.44, p = 0.01) in the Pecs block group. Additionally, OME for the first twelve hours following surgery remained slightly lower in the pectoral group (47.07 vs 49.72, p = 0.76), however did not reach significance. PACU antiemetic requirement also trended lower in the pectoral block group with 17.24% of block patients receiving antiemetics vs 24.39% of patients who did not receive a block (p = 0.47). This trend continued through the first twelve hours following surgery (34.48% vs 43.59%, p = 0.45). There were no complications related to the administration of the Pecs blocks.

**CONCLUSION:** Pectoral nerve blocks provide a safe and effective means of perioperative pain control in breast reduction mammoplasty patients. Administration did not substantially increase anesthesia time but did significantly reduce the need for intraoperative opioid analgesia.
